Results 91 to 100 of about 3,487 (207)

Systemic inflammation response index is a useful indicator in distinguishing MOGAD from AQP4-IgG-positive NMOSD

Frontiers in Immunology
ObjectiveTo identify reliable immune-inflammation indicators for distinguishing myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) from anti–aquaporin-4 immunoglobulin G (AQP4-IgG)-positive neuromyelitis optica spectrum disorders ...
Lei Wang, Ruihong Xia, Xiangliang Li, Jingli Shan, Shengjun Wang   +4 more
doaj   +1 more source

Serum NfL and EGFR/NfL ratio mRNAs as biomarkers for phenotype and disease severity of myelin oligodendrocyte glycoprotein IgG-associated disease

Frontiers in Immunology
Background and purposeMyelin oligodendrocyte glycoprotein (MOG) IgG is frequently elevated in pediatric patients with acquired demyelinating syndrome (ADS).
Xin Wang, Yi Qu, Jiayu Fan, Huiqiang Ren
doaj   +1 more source

Bolest povezana s mijelinskim oligodendrocitnim glikoproteinom (MOGAD)

Myelin Oligodendrocyte Glycoprotein (MOG) is a component of myelin found in the mammalian Central Nervous System (CNS) and is present on both myelin sheaths and oligodendrocyte plasma membranes.
Singh, Yasho-Victoria Gayatri Calla
core   +1 more source

MOGAD in South Wales: Diagnostic Evolution and Disease Epidemiology [PDF]

Background: Myelin oligodendrocyte glycoprotein antibody‐associated disease (MOGAD) is a rare antibody‐mediated inflammatory demyelinating disorder. In 2023, new international consensus diagnostic criteria were agreed.
Voase, Sophie, Pearson, Owen, Wood, Callum, Tallantyre, Emma, Robertson, Neil P., Jolles, Stephen, Harding, Katharine, Ingram, Gillian, te Water Naudé, Johann, Woodhall, Mark, Waters, Patrick, Wynford‐Thomas, Ray   +11 more
core   +1 more source

Rapid differentiation of MOGAD and MS after a single optic neuritis [PDF]

BACKGROUND: Optic neuritis (ON) is a common manifestation of multiple sclerosis (MS) and myelin-oligodendrocyte-glycoprotein IgG-associated disease (MOGAD).
Ringelstein, M., Cerdá-Fuertes, N, Gernert, J, A, Kornek, B, Stolowy, N, Ayroza Galvão Ribeiro Gomes, A.B., Schneider-Gold, C, Bsteh, G., Cerdá-Fuertes, N., Albrecht, P, Salmen, A, Hellwig, K., Stellmann, Jan-Patrick, Ayzenberg, I, Ayzenberg, I., Ringelstein, M, Pröbstel, A-K, Weise, M., Bsteh, G, Schwake, C., Albrecht, P., Stellmann, J. P., Havla, J., Pröbstel, A.-K., Oertel, F. C., Papadopoulou, A, Hellwig, K, Ayroza Galvão Ribeiro Gomes, A, B, Pakeerathan, T., Kornek, B., Gernert, J.A., Oertel, F.C., Ayroza Galvão Ribeiro Gomes, A B, Duchow, A, S, Gold, R., Gold, R, Duchow, A.S., Pakeerathan, T, Paul, F., Stellmann, J P, Duchow, A. S., Gernert, J A, Pröbstel, A.K., Stellmann, J.P., Kulsvehagen, L., Ayroza Galvão Ribeiro Gomes, A. B., Aktas, O, Oertel, F C, Schneider-Gold, C., Kulsvehagen, L, Duchow, A S, Salmen, A., Weise, M, Kümpfel, T., Schwake, C, Kümpfel, T, Gernert, J. A., Oertel, F, C, Havla, J, Aktas, O., Papadopoulou, A., Paul, F, Stolowy, N.   +62 more
core   +2 more sources

Brain atrophy in NMOSD and MOGAD: a meta-analysis of volumetric and DTI biomarkers

Frontiers in Neurology
BackgroundNeuromyelitis optica spectrum disorder (NMOSD) and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) are demyelinating diseases of the central nervous system. Brain atrophy is well recognized in multiple sclerosis; however,
Ariel Rechtman, Ariel Rechtman, Omri Zveik, Omri Zveik, Adi Vaknin-Dembinsky, Adi Vaknin-Dembinsky   +5 more
doaj   +1 more source

The Varying Faces of MOGAD: A Case Series

Annals of African Medicine
Myelin oligodendrocyte glycoprotein-immunoglobulin G (MOG-IgG)-associated disease (MOGAD) is an immune mediated demyelinating disorder initially described as a subtype of neuromyelitis optica spectrum disorder with antibodies against MOG. Recently, it has been described as a separate disease entity with unique clinical and radiological features.
openaire   +2 more sources

Confusing Onset of MOGAD in the Form of Focal Seizures

Neurology International
MOGAD is a demyelinating syndrome with the presence of antibodies against myelin oligodendrocyte glycoprotein, which is, next to multiple sclerosis and the neuromyelitis optica spectrum, one of the manifestations of the demyelinating process, more common in the pediatric population.
Małgorzata Jączak-Goździak, Barbara Steinborn   +1 more
openaire   +3 more sources

A Case of MOGAD Presenting with Concurrent Intracranial Hypertension

, 2023
The manifestations of myelin oligodendrocyte glycoprotein associated disease (MOGAD) are diverse and include acute demyelinating encephalomyelitis, transverse myelitis and optic neuritis. Optic neuritis and intracranial hypertension have been reported to
Mairghread Casey; Angela Chen; Peter Quiros; Laura Bonelli
core  

Frequent early cognitive impairment in both pediatric MS and MOGAD

Background: Studies on early cognitive impairment (CI) in pediatric multiple sclerosis (MS) are heterogeneous and data on pediatric myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) are ...
Michiel Simon Jan Buijze, Sandy Molenaar, Rinze Frederik Neuteboom, Willemijn Marije Carolien van der Vlugt, Rosa Verkerk, Maud Alida Quist   +5 more
core   +1 more source